CKD8 / 19 INHIBITORS
PE0013162026A1Pending Publication Date: 2026-07-02JOINT CO BIOCAD
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- PE2026000713
- Authority / Receiving Office
- PE · PE
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-07-31
- Filing Date
- 2019-07-31
- Publication Date
- 2026-07-02
Abstract
The present invention relates to compounds of formula I having the properties of CDK8 / 19 inhibitors; to pharmaceutical compositions comprising such compounds; and to the use of these as a medicament for treating oncological or hemato-oncological diseases and disorders. It refers to a compound of formula I or a pharmaceutically acceptable salt or stereoisomer thereof, wherein: L is -??2 -, -?(O)-; R is (a), (b) and (c); R1 is (a), (d), (e), among others.
Need to check novelty before this filing date? Find Prior Art